Share:  
|
PAGE
MENU

MACS-5

In Canada today, approximately 7% of infants are born preterm. Approximately half of these infants are exposed to multiple courses of antenatal corticosteroids (ACS). A randomized controlled trial is underway to determine the effectiveness of this important antenatal treatment.

Recruitment for the main trial began in April 2001. The MACS-5 follow-up starts summer 2006.

E-mail macs@sw.ca for more information.

MACS-5 logo

ISRCTN72654148